NEWS
Dr. Rotenberg is named 2025 Harrington Scholar-Innovator Award recipient.
Congratulations to Alexander Rotenberg, MD, PhD. for being named one of ten 2025 Harrington Scholar-Innovator Award recipient by the Harrington Discovery Institute, for his project titled ‘Gene therapy for a rare inherited disease, Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)’.
Dr. Rotenberg is the Director of the Neuromodulation Program at Boston Children’s Hospital and a Professor of Neurology at Harvard Medical School. Dr. Rotenberg has been working with SSADHD patients for the last ten years.
Click here to read more about the award.